Peter J. Grant

Active 1986–2024

Also published as
Peter J Grant
93
Papers
22,057
Citations
78
h-index
93
i10-index

Citations

Citations per year for Peter J. Grant1986: 2 citations1987: 1 citations1989: 1 citations1990: 1 citations1991: 2 citations1992: 2 citations1993: 2 citations1994: 1 citations1995: 3 citations1996: 5 citations1997: 16 citations1998: 44 citations1999: 31 citations2000: 79 citations2001: 66 citations2002: 81 citations2003: 122 citations2004: 116 citations2005: 136 citations2006: 111 citations2007: 124 citations2008: 116 citations2009: 126 citations2010: 112 citations2011: 125 citations2012: 100 citations2013: 109 citations2014: 172 citations2015: 143 citations2016: 174 citations2017: 156 citations2018: 128 citations2019: 492 citations2020: 807 citations2021: 775 citations2022: 532 citations2023: 361 citations2024: 486 citations2025: 209 citations2026: 1 citations1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,606 citing papers, 17.4% of this breakdownUnited Kingdom: 861 citing papers, 9.3% of this breakdownItaly: 589 citing papers, 6.4% of this breakdownChina: 569 citing papers, 6.1% of this breakdownGermany: 504 citing papers, 5.4% of this breakdownNetherlands: 326 citing papers, 3.5% of this breakdownFrance: 316 citing papers, 3.4% of this breakdownSpain: 304 citing papers, 3.3% of this breakdownCanada: 293 citing papers, 3.2% of this breakdownSweden: 277 citing papers, 3% of this breakdownAustralia: 270 citing papers, 2.9% of this breakdownDenmark: 209 citing papers, 2.3% of this breakdown
0%17.4%Other 33.8%

Fields

  • Medicine73.1%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Neuroscience6%
  • Psychology1.4%
  • Immunology and Microbiology1.4%
  • Health Professions0.8%
  • Other2.5%

Topics

  • Diabetes Treatment and Management6.7%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.8%
  • Blood properties and coagulation3%
  • Cardiovascular Function and Risk Factors2.5%
  • Metabolism, Diabetes, and Cancer2.5%
  • Blood Coagulation and Thrombosis Mechanisms2.2%
  • Other79.3%

Coauthors

All papers

Open in search
  1. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Colin Baigent, Marianne Brodmann, Héctor Bueno, Claudio Ceconi, Ovidiu Chioncel, Andrew J.S. Coats, Jean-Philippe Collet, Peter W. Collins, Bernard Cosyns, Carlo Di Mario, Miles Fisher, Donna Fitzsimons, Sigrun Halvorsen, Dominique Hansen, Arno W. Hoes, Richard I. G. Holt, Philip Home, Hugo A Katus, Kamlesh Khunti, Michel Komajda, Ekaterini Lambrinou, Ulf Landmesser, Basil S Lewis, Cecilia Linde, Roberto Lorusso, François Mach, Christian Mueller, Franz-Josef Neumann, Frederik Persson, Steffen E Petersen, Anna Sonia Petronio, Dimitrios J Richter, Giuseppe M.C. Rosano, Peter Rossing, Lars Rydén, Е. V. Shlyakhto, Iain A Simpson, Rhian M. Touyz, William Wijns, Matthias Wilhelm, Bryan Williams, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen, Heikki Huikuri, Isabelle Johansson, Peter Jüni, Maddalena Lettino, Nikolaus Marx, Linda Mellbin, Carl Johan Östgren, Bianca Rocca, Marco Roffi, Naveed Sattar, Petar Seferovic, Miguel Sousa-Uva, Paul Valensi, David C Wheeler, Stephan Windecker, Victor Aboyans, Colin Baigent, Jean-Philippe Collet, Verónica Dean, Victoria Delgado, Donna Fitzsimons and 72 more - European Heart Journal 2019 cited by 4,870

  2. Circadian Rhythm and Sleep Disruption: Causes, Metabolic Consequences, and Countermeasures

    Authors: , , , , , - Endocrine Reviews 2016 cited by 701

  3. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christi Deaton, Çetin Erol, Robert Fagard, Roberto Ferrari, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Patrizio Lancellotti, Aleš Linhart, Petros Nihoyannopoulos, Massimo Piepoli, Piotr Ponikowski, Per Anton Sirnes, Juan Tamargo, Michał Tendera, Adam Torbicki, William Wijns, Stephan Windecker, Document Reviewers, Guy De Backer, Per Anton Sirnes, Eduardo Alegría Ezquerra, Angelo Avogaro, Lina Badimón, Е. И. Баранова, Helmut Baumgartner, John Betteridge, Antonio Ceriello, Robert Fagard, Christian Funck‐Brentano, Dietrich C. Gulba, David Hasdai, Arno W. Hoes, John Kjekshus, Juhani Knuuti, Philippe Kolh, Eli Lev, Christian Mueller, Ludwig Neyses, Peter M. Nilsson, Joep Perk, Piotr Ponikowski, Željko Reiner, Naveed Sattar, Volker Schächinger, André Scheen, Henrik Schirmer, Anna Strömberg, Svetlana Sudzhaeva, Juan Tamargo - European Heart Journal 2013 cited by 1,958

  4. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Norman E. Lepor, Christos S. Mantzoros, Chantal Mathieu, Christian W. Mende, Erin D. Michos, Javier Morales, Jorge Plutzky, Richard E. Pratley, Kausik K Ray, Peter Rossing, Naveed Sattar, Peter E.H. Schwarz, Eberhard Standl, Philippe Gabríel Steg, Lâle Tokgözoğlu, Jaakko Tuomilehto, Guillermo E Umpierrez, Paul Valensi, Matthew R. Weir, John Wilding, Eugene E. Wright - Metabolism 2024 cited by 76

  5. Guideline recommendations and the positioning of newer drugs in type 2 diabetes care

    Authors: , , , , , , - The Lancet Diabetes & Endocrinology 2020 cited by 153

  6. Nutrition and the circadian system

    Authors: , , , - British Journal Of Nutrition 2016 cited by 218

  7. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism

    Authors: , , , , - Biochemical Journal 2004 cited by 627

  8. Diabetes mellitus as a prothrombotic condition

    Authors: - Journal of Internal Medicine 2007 cited by 444

  9. Neprilysin, obesity and the metabolic syndrome

    Authors: , , , , , , , , , , - International Journal of Obesity 2010 cited by 171

  10. Identification, classification, and expression of RAGE gene splice variants

    Authors: , , , , , , , - The FASEB Journal 2007 cited by 352

  11. Heritability of Clot Formation, Morphology, and Lysis

    Authors: , , , - Arteriosclerosis Thrombosis and Vascular Biology 2007 cited by 177

  12. Increasing Circulating IGFBP1 Levels Improves Insulin Sensitivity, Promotes Nitric Oxide Production, Lowers Blood Pressure, and Protects Against Atherosclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , - Diabetes 2012 cited by 141

  13. The influence of type 2 diabetes on fibrin structure and function

    Authors: , , - Diabetologia 2005 cited by 221

  14. The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    Authors: , - European Heart Journal 2019 cited by 204

  15. Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus

    Authors: , , , - Diabetologia 2006 cited by 178

  16. The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis

    Authors: , , , , , , - Journal of Thrombosis and Haemostasis 2013 cited by 175

  17. Sodium‐Glucose Cotransporter 2 Inhibitors, All‐Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta‐Analysis and Meta‐Regression

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American Heart Association 2021 cited by 27

  18. Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man

    Authors: , , - International Journal of Obesity 2007 cited by 339

  19. The genetics of haemostasis: a twin study

    Authors: , , , , - The Lancet 2001 cited by 293

  20. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mahir Karakas, Geoffrey H. Tofler, Angela Silveira, Gerjan Navis, Kurt Lohman, Ming‐Huei Chen, Annette Peters, Anuj Goel, Jemma C. Hopewell, John C. Chambers, Danish Saleheen, Per Lundmark, Bruce M. Psaty, Rona J. Strawbridge, Bernhard O. Boehm, Angela M. Carter, Christa Meisinger, John F. Peden, Joshua C. Bis, Barbara McKnight, John Öhrvik, Kent D. Taylor, Maria Grazia Franzosi, Udo Seedorf, Rory Collins, Anders Franco‐Cereceda, Ann‐Christine Syvänen, Alison H. Goodall, Lisa R. Yanek, Mary Cushman, Martina Müller‐Nurasyid, Aaron R. Folsom, Saonli Basu, Nena Matijevic, Wiek H. van Gilst, Jaspal S. Kooner, Albert Hofman, John Danesh, Robert W. Clarke, James B. Meigs, Sekar Kathiresan, Muredach P. Reilly, Norman Klopp, Tamara B. Harris, Bernhard R. Winkelmann, Peter J. Grant, Hans L. Hillege, Hugh Watkins, Timothy D. Spector, Lewis C. Becker, Russell P. Tracy, Winfried März, André G. Uitterlinden, Per Eriksson, François Cambien, Pierre‐Emmanuel Morange, Wolfgang Köenig, Nicole Soranzo, Pim van der Harst, Ching‐Ti Liu, Anders Hamsten, Georg Ehret, Patricia B. Munroe, Kenneth Rice, Murielle Bochud, Andrew D. Johnson, Daniel I. Chasman, Albert V. Smith, Martin D. Tobin, Germaine C. Verwoert and 464 more - Journal of the American Heart Association 2017 cited by 134

  21. Functional analysis of fibrin γ-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness

    Authors: , , , , , , , - Blood 2007 cited by 120

  22. Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease

    Authors: , - New England Journal of Medicine 2000 cited by 808

  23. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease

    Authors: , - Blood 2000 cited by 491

  24. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

    Authors: , , , , , , , , , , , , , , , , , - Genes and Immunity 2002 cited by 386